Eversept Partners LP Takes Position in Select Medical Holdings Corporation $SEM

Eversept Partners LP purchased a new stake in Select Medical Holdings Corporation (NYSE:SEM) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 906,100 shares of the health services provider’s stock, valued at approximately $13,456,000. Eversept Partners LP owned 0.73% of Select Medical at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Clough Capital Partners L P acquired a new stake in shares of Select Medical in the fourth quarter valued at about $2,569,000. Balyasny Asset Management L.P. acquired a new stake in shares of Select Medical in the fourth quarter valued at about $839,000. Bridgeway Capital Management LLC increased its stake in shares of Select Medical by 7.1% in the fourth quarter. Bridgeway Capital Management LLC now owns 788,380 shares of the health services provider’s stock valued at $11,707,000 after buying an additional 52,043 shares during the period. Guggenheim Capital LLC bought a new stake in shares of Select Medical during the 4th quarter valued at about $556,000. Finally, Schonfeld Strategic Advisors LLC bought a new stake in shares of Select Medical during the 4th quarter valued at about $2,745,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Upgrades and Downgrades

SEM has been the topic of several research analyst reports. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Weiss Ratings upgraded Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Mizuho restated a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. One investment analyst has rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Select Medical currently has an average rating of “Hold” and a consensus target price of $15.50.

Select Medical Stock Down 0.5%

Shares of NYSE:SEM opened at $16.54 on Thursday. The business’s 50 day simple moving average is $16.48 and its two-hundred day simple moving average is $15.86. The firm has a market cap of $2.05 billion, a P/E ratio of 15.60, a PEG ratio of 0.96 and a beta of 1.01. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $16.99.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.07). The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, research analysts forecast that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were issued a $0.0625 dividend. The ex-dividend date was Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio is presently 23.58%.

Select Medical declared that its Board of Directors has initiated a stock repurchase program on Thursday, February 19th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the health services provider to buy up to 49.5% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.